Gemcitabine, oxaliplatin and dexamethasone as salvage treatment for elderly patients with refractory and relapsed peripheral T-cell lymphoma.
about
Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentaryT-cell lymphomas, a challenging disease: types, treatments, and future.Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial.GDP (Gemcitabine, Dexamethasone, and Cisplatin) Is Highly Effective and Well-Tolerated for Newly Diagnosed Stage IV and Relapsed/Refractory Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.Gemcitabine, dexamethasone, and cisplatin (GDP) as salvage chemotherapy for patients with relapsed or refractory peripheral T cell lymphoma-not otherwise specified.Therapeutic Options for Aggressive T-Cell Lymphomas.The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus CHOP in patients with newly diagnosed peripheral T-cell lymphoma with analysis of biomarkers.Outcomes following front-line chemotherapy in peripheral T-cell lymphoma: 10-year experience at The Royal Marsden and The Christie Hospital.Retrospective Study of Pegaspargase, Gemicitabine, Oxaliplatin and Dexamethasone (Peg-GemOD) as a First-Line Therapy for Advanced-Stage Extranodal NK/T Cell Lymphoma.CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial.
P2860
Q28088365-B00BAAB6-E706-4879-8299-311602D02416Q30244553-E62F1ACD-D4C7-4069-9F4E-F761E4A48080Q33425005-D945EEFD-7BBA-4EE0-8C60-FA8C35B23E8DQ33429990-EB4E4841-960B-443C-B001-18BBB6D3AF83Q33436867-C544F2FC-FF91-4237-9C37-8D25278D0AE7Q38675843-6E484196-1C4D-48BA-B612-931F52FB4357Q48301800-8B272D53-A987-4635-BE78-6F5F01B815A1Q48559035-1BED36CB-C747-48B3-B0FD-488E4993F20AQ50895128-A9E60B30-2D8B-424A-BF04-6E499CC55F5DQ53828417-4680B2A6-C2BF-4503-921C-888BA71F5170
P2860
Gemcitabine, oxaliplatin and dexamethasone as salvage treatment for elderly patients with refractory and relapsed peripheral T-cell lymphoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Gemcitabine, oxaliplatin and d ...... ed peripheral T-cell lymphoma.
@en
Gemcitabine, oxaliplatin and d ...... ed peripheral T-cell lymphoma.
@nl
type
label
Gemcitabine, oxaliplatin and d ...... ed peripheral T-cell lymphoma.
@en
Gemcitabine, oxaliplatin and d ...... ed peripheral T-cell lymphoma.
@nl
prefLabel
Gemcitabine, oxaliplatin and d ...... ed peripheral T-cell lymphoma.
@en
Gemcitabine, oxaliplatin and d ...... ed peripheral T-cell lymphoma.
@nl
P2093
P2860
P1433
P1476
Gemcitabine, oxaliplatin and d ...... ed peripheral T-cell lymphoma.
@en
P2093
Li-fang Zou
Yan Zhuang
Yi-min Cheng
Yi-yun Yao
P2860
P304
P356
10.3109/10428194.2012.739286
P577
2012-11-19T00:00:00Z